TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/1/23 20:15 | 8/30/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | S | -103 | 22.47 | 0 | -5 | -1 | 406 | D | ||||||||||||||
3/1/23 19:56 | 2/27/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | M.dm | 1,216 | 14.74 | 0 | 83 | 30 | 357 | D | ||||||||||||||
3/1/23 19:56 | 2/27/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | S.dm | -1,444 | 17.50 | 0 | -83 | -19 | 357 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |